Citation Impact
Citing Papers
Interleukin-17 Receptor-Like Gene Is a Novel Antiapoptotic Gene Highly Expressed in Androgen-Independent Prostate Cancer
2006
Redox Regulation of Cell Survival
2008
Apoptosis-Related Gene and Protein Expression in Human Lymphoma Xenografts (Raji) After Low Dose Rate Radiation Using 67 Cu-2IT-BAT-Lym-1 Radioimmunotherapy
2001
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
2014 Standout
Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities
2002
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
Chemosensitivity linked to p73 function
2003 StandoutNobel
Germline development from human pluripotent stem cells toward disease modeling of infertility
2012 StandoutNobel
Differential expression of 37 selected genes in hormone‐refractory prostate cancer using quantitative taqman real‐time RT‐PCR
2004
Environmental and health effects of the herbicide glyphosate
2017 Standout
The tor pathway: a target for cancer therapy
2004 Standout
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
p63 expression correlates with sensitivity to the Eg5 inhibitor AZD4877 in bladder cancer cells
2012
Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression
2011
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy
2008
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
TGF-β signaling: positive and negative effects on tumorigenesis
2002
PPARγ as a new therapeutic target in inflammatory bowel diseases
2006
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
2006
Pfam: the protein families database
2013 Standout
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
2010 Nature
Cancer Statistics, 2006
2006 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
DrugBank 4.0: shedding new light on drug metabolism
2013 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
p63 and epithelial biology
2006
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women
2012
Molecular mechanisms of cisplatin resistance
2011 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
The carbohydrate-active enzymes database (CAZy) in 2013
2013 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
The RCSB Protein Data Bank: new resources for research and education
2012
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Tea Beverage in Chemoprevention of Prostate Cancer: A Mini-Review
2003
Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells
2002
Opposite Role of Ras in Tumor Necrosis Factor-α-Induced Cell Cycle Regulation: Competition for Raf Kinase
2001
p53 in health and disease
2007 Standout
Live or let die: the cell's response to p53
2002 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
The dark side of light: the damaging effects of UV rays and the protective efforts of MAP kinase signaling in the epidermis
2004
TGFβ in Cancer
2008 Standout
Activation of the Erk Pathway Is Required for TGF-β1-Induced EMT In Vitro
2004
Growth Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Green Tea Constituent (-)-Epigallocatechin-3-gallate in Androgen-Sensitive and Androgen-Insensitive Human Prostate Carcinoma Cells
2000
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma
2003
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
The basics of epithelial-mesenchymal transition
2009 Standout
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
Role of the newer p53 family proteins in malignancy
2001 StandoutNobel
Structure and signalling in the IL-17 receptor family
2009 Standout
The p53 pathway: positive and negative feedback loops
2005 Standout
Cancer-related inflammation
2008 StandoutNature
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family
2005
The immune epitope database (IEDB) 3.0
2014 Standout
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
2012
Factors affecting effluent quality from fill-and-draw activated sludge reactors
1977
Early Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Lung Cancer Progression
2004
Pancreatic cancer–associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation
2013
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness
2002
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
2002
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts
1997
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Impaired TGF-β Responses in Peripheral T Cells of Gαi2−/− Mice
2005 StandoutNobel
DNA Methylation and Apoptosis Resistance in Cancer Cells
2013
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Rapamycin Potentiates Transforming Growth Factor β-Induced Growth Arrest in Nontransformed, Oncogene-Transformed, and Human Cancer Cells
2002
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Inflammatory Bowel Disease
2010 Standout
A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain
2001
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
2005
Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes
2002
Tumor Necrosis Factor-α Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids
2003
p63 regulates glutaminase 2 expression
2013
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
2002
A review of soluble microbial products (SMP) in wastewater treatment systems
1999 Standout
Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1
2003
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
2010
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Works of Sung Gil being referenced
Embryonic stem cell-like cells established by culture of adult ovarian cells in mice
2010
[Frequent epigenetic inactivation of XAF1 by promotor hypermethylation in human colon cancers].
2005
Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
2000
Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
2003
[Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells].
2005
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors
1998
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors
1998
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
1995
Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure
2007
Frequent alteration of p63 expression in human primary bladder carcinomas.
2000